Sandoz Offers Further Financials Ahead Of Spinoff
Supplement To Listing Prospectus Includes Combined And Pro-Forma First-Half Statements
With around a month to go until Sandoz is expected to become a standalone company following its spinoff from parent Novartis, the firm has published additional financial information ahead of a shareholders meeting in mid-September.
